A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Al-Abdullah, Ismail, Ph.D.

Ismail Al-Abdullah, Ph.D. Research
Coating Human Islets with Macromolecular Heparin
This project is carried out in collaboration with University of Uppsala Sweden.  Achieving successful reversal of diabetes with minimum Heparin precoated islet mass would have a major impact in translating the result generated from this study to clinical practice to use islet isolated from a single donor to reverse a single type 1 diabetic recipient.
Growth Factors in Culture Media Supplement to Improve Islet Quality and Quantity
This proposal will test the hypothesis that culturing islets in serum free medium supplemented with growth factors such as gastrin, EGF and exendin can promote islet function, yields; promote proliferation of islet progenitor cells to ultimate transplantation of islets from a single donor.

The Role of alpha-glutathione S-transferase (α-GST) in Human Islets
The ultimate goal of this study is to develop a simple, fast and reliable biomarker to monitor islet function and survival. Based on our feasibility study that islets are indeed contain and secrete α-GST. This novel biomarker will be used to monitor islet function during the isolation and post culture. We intend to use this biomarker to monitor islet integrity and develop the best conditions for islet recovery and survival post transplant.
Collaboration with the University of Uppsala
Our main focus on this collaboration is to further improve our islet isolation procedure for enhancing and improving islet quality so that a single diabetic patient could be transplanted and reverse diabetes with islets isolated from a single donor.
Collaboration on Non-Human Primate Islet Transplantation Protocol
We have initiated this collaboration with Dr. Defu Zeng and University of Maryland for induction of tolerance in the recipients. Donor pancreas from non-human primate was shipped and the isolated islets when transplanted into diabetic mice, diabetes were reversed.  The outcome of this study results obtain from this study will have major impact for FDA approval for eventual application of novel strategies for tolerance induction to cure type 1 diabetic patients with islets isolated from cadaveric donors.
Development of Novel Peptide for Collagenase and Neutral Protease Activities
Collaboration with Dr. Markus Kalkum from the immunology department at City of Hope has been established and we have already developed a novel peptide for collagenase and neutral protease activities assessment to define a better enzymes for pancreas digestion to free the islets for ultimate goal to transplant islets into a single diabetic recipient isolated from a single cadaveric donor pancreas.

Lab Members

Ismail Al-Abdullah, Ph.D.
Research Professor
626-246-HOPE (4673) ext. 60109
Luis Valiente
Senior Research Associate
626-246-HOPE (4673) ext. 65639
Shiela Bilbao
Research Associate II
626-246-HOPE (4673) ext. 61410
Alina Oancea, M.D.
Research Associate II
626-246-HOPE (4673) ext. 63923
Brian McFadden
626-246-HOPE (4673) ext. 33101
Research Associate I
City of Hope combines compassionate care with the best and most innovative science. Our 100+ acre campus is designed to meet the full range of needs of our patients and families. This guide is designed to help you take advantage of all that is offered at City of Hope - Duarte.
To make an appointment for yourself, a family member or a friend, please complete and submit our Become a Patient Request Form, or call City of Hope at
800-826-HOPE (4673).
Contact Us
Phone: (800) 826-HOPE (4673)
Hours: M – F, 8 a.m. to 5 p.m. (PST)
Calls received after 5 p.m. will be returned the next business day.
Patient Care Overview

The Sheri & Les Biller Patient and Family Resource Center embodies the heart and soul of City of Hope’s mission to care for the whole person.
Info for Referring Physicians
City of hope welcomes patient referrals from physicians throughout the world. City of Hope is located near northeast Los Angeles, in Duarte, California.

  • Brain surgery is not for the faint of heart. It takes courage, as well as curiosity and compassion. The truly great surgeons also have a desire to find new, and better ways, of healing the brain. Enter Behnam Badie, M.D., chief of neurosurgery at City of Hope. Now a pioneer in brain tumor treatment, Badie enter...
  • Elizabeth Budde, M.D., Ph.D., wants to encourage infighting. She aims to turn the immune system on itself — to the benefit of patients with acute myeloid leukemia, or AML. AML arises when abnormal white blood cells grow out of control, amassing in the bone marrow and interfering with normal blood cell developme...
  • Six, to date; more soon. Outpatient bone marrow transplants, that is. Finding new ways to deliver quality care with the greatest benefit is a priority for a patient-centered institution like City of Hope. For example, not every bone marrow transplant patient needs to check into the hospital for treatment. In fa...
  • The best measure of success in the fight against cancer is in lives saved and families intact, in extra days made special simply because they exist. Yuman Fong, M.D., chair of the Department of Surgery at City of Hope, understands what precedes that special awareness. When cancer strikes, one minute a person ma...
  • In cancer, expertise matters. So do survival rates, patient safety, patient services and many other factors. City of Hope understands this, as does U.S.News & World Report. The magazine’s 2014-2015 list of best hospitals for cancer once again includes City of Hope, ranking the institution 12 out of 900 elig...
  • At 29, Kommah McDowell was a successful young professional engaged to be married to her best friend. She worked in the financial services sector and kick-boxed to keep in shape and to relax. Then came the diagnosis of triple-negative inflammatory breast cancer, a rare and very aggressive form of breast cancer. ...
  • The well-known drug tamoxifen might not always be the best choice for premenopausal women who have undergone treatment for breast cancer and face a heightened risk of recurrence. A new study suggests that the aromatase inhibitor exemestane, or Aromasin, works slightly better than tamoxifen in preventing cancer ...
  • At age 44, Bridget Hanchette, a mother of three from La Crosse, Wisconsin, was diagnosed with grade IV glioblastoma, the most aggressive type of malignant brain tumor. The cancer grows and spreads quickly, making it difficult to treat. Most patients with this diagnosis are not given much hope, but Hanchette’s i...
  • Survival rates for childhood cancer have improved tremendously over the past few decades, but postcancer care hasn’t always kept up. More children than ever are now coping with long-term complications and side effects caused by their disease and treatment — one of those being learning difficulties. A new ...
  • When Sheldon Querido, a retired manufacturer’s representative, was diagnosed with bladder cancer, his doctor told him that he’d need to have his bladder removed – and that he’d have to wear an external urine-collection bag for the rest of his life. “My first response was ‘I donR...
  • To stop smoking, two approaches might be better than one. A new study has found that using the medication varenicline, or Chantix – along with nicotine patches – was more effective than the medicine alone in helping people quit. The study, conducted by Stellanbosch University in Cape Town, South Africa, and pub...
  • John Cloer was three months shy of his third birthday in 2004 when he was diagnosed with acute lymphoblastic leukemia. For the next three and a half years, he received chemotherapy at City of Hope, finally obtaining long-term remission. His parents Bill and Gina, along with John and his younger brother Steve, r...
  • News about the risks or benefits of widespread cancer screening seem to arrive daily – 3D mammography for breast cancer, CT scans for lung cancer, PSA tests for prostate cancer and now pelvic exams for some women’s cancers. Missing in the headlines is a reflection of how cancer detection is evolving. Today’s ca...
  • Adults with sickle cell disease soon may have a new treatment option: bone marrow transplants. Children with sickle cell disease have been treated successfully with transplantation of bone marrow, more officially known as hematopoietic stem cells, from other people. But the procedure has been less successful in...
  • New pelvic exam recommendations or not, women shouldn’t give up those routine gynecological appointments. The revised guidelines from the American College of Physicians exempt most women from pelvic examinations, but a cancer specialist at City of Hope says women should still plan on regular visits with t...